17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51.
Max Planck Institute of Psychiatry
Structure-Affinity Relationship Analysis of Selective FKBP51 Ligands.
Max Planck Institute of Psychiatry
Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control.
Max Institute of Psychiatry
Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52.
Max Planck Institute of Psychiatry
Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52.
Max Planck Institute of Psychiatry
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
Johann Wolfgang Goethe University
Antascomicin B stabilizes FKBP51-Akt1 complexes as a molecular glue.
Technical University Darmstadt
Structure-based discovery of small molecule inhibitors of FKBP51-Hsp90 protein-protein interaction.
Karolinska Institutet
Macrocyclization strategy for improving candidate profiles in medicinal chemistry.
Gachon University
Structure-Based Discovery of a New Selectivity-Enabling Motif for the FK506-Binding Protein 51.
Technical University Darmstadt
Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.
University of Michigan
Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors.
Technical University Darmstadt
Hybrid Screening Approach for Very Small Fragments: X-ray and Computational Screening on FKBP51.
Boehringer Ingelheim Pharma
A Novel Decalin-Based Bicyclic Scaffold for FKBP51-Selective Ligands.
Max Planck Institute of Psychiatry
Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins.
Max Planck Institute of Psychiatry
Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same
Arbutus Biopharma
Inhibitors of protein arginine methyltransferase 5 (PRMT5), pharmaceutical products thereof, and methods thereof
Pharmablock Sciences (Nanjing)